U.S Peripheral CTO Device Market Size, Share, Value & Report 2023-2030

U.S. Peripheral CTO Device Market Outlook, Opportunities, Competitive Analysis and Market Forecast 2023-2030

<h2>U.S. Peripheral CTO Device Market is segmented By Device Type (Crossing CTO device, TruePath, Viance Device, Re-entry device, CenterCross CTO device, Prodigy, and CrossLock, Others), By End-user (Hospitals, Ambulatory Surgical Centers, Others) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030</h2>

&nbsp;

<h3>U.S. Peripheral CTO Device Market Overview</h3>

<blockquote>
U.S. Peripheral CTO Device Market&nbsp;is estimated to reach at a CAGR of 6.5% during the forecast period (2023-2030)
</blockquote>

Chronic total occlusions (CTOs) are a challenging lesion subset in the peripheral circulation. CTOs, particularly long or heavily calcified, have been the domain of surgeons for distal bypass. Although surgery is still an option in some patients, the explosion of crossing technologies and atherectomy devices has allowed several <a href="https://www.datamintelligence.com/research-report/endovascular-aneurysm-repair-market" target="_blank">endovascular</a> specialists to tackle these lesions with greater success.

&nbsp;

<h3>U.S. Peripheral CTO Device Market&nbsp;Scope</h3>

<table cellspacing="0">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			CAGR
			</td>
			<td>
			6.5%
			</td>
		</tr>
		<tr>
			<td>
			Size Available for Years
			</td>
			<td>
			2021-2030
			</td>
		</tr>
		<tr>
			<td>
			Forecast Period
			</td>
			<td>
			2023-2030
			</td>
		</tr>
		<tr>
			<td>
			Data Availability
			</td>
			<td>
			Value (US$)
			</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			Device Type, and End-user
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For More Insights <a href="https://www.datamintelligence.com/download-sample/u-s-peripheral-cto-device-market" target="_blank">Download Sample</a>

&nbsp;

<h3>U.S. Peripheral CTO Device Market Dynamics and Trends</h3>

The U.S. peripheral CTO device market is growing due to the major driving forces being the increasing number of regulatory approvals and pipeline products.

The increasing number of regulatory approvals is expected to boost market growth.

The increasing number of regulatory approvals is expected to boost the market. For instance, on April 8, 2020, The US Food and Drug Administration (FDA) granted a 510(k) clearance for Israel-based Nitiloop&rsquo;s NovaCross CTO Microcatheter, which is intended for the treatment of chronic total occlusion (CTO) before PTCA or stent intervention, also, on February 23, 2022, Teleflex CTO PCI specialty <a href="https://www.datamintelligence.com/research-report/catheters-market" target="_blank">catheters</a> and guidewires received FDA clearance for expanded indication. Furthermore, the increasing procedural success with CTO devices is fueling market growth.

Such as, an international multi-center registry of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) was presented on May 20, 2022, with late-breaking clinical research at the Society for Cardiovascular Angiography &amp; Interventions (SCAI) 2022 Scientific Sessions, and the findings of which show an increase in the success and efficiency of CTO PCI without an increase in major adverse cardiac events (MACE).

The availability of substitute products hampers the market growth. 

However, the increasing number of substitute products, such as B-Laser Atherectomy System for Peripheral Artery Disease (PAD) and PACT Admiral Drug-Coated Balloon (DCB), is restraining the growth of the market.

Industry analysis

The U.S. peripheral CTO device market report, will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, Etc.

<h3>U.S. Peripheral CTO Device Market&nbsp;Segmentation Analysis</h3>

The crossing CTO device segment is predicted to dominate the market during the forecast period (2023-2030)

The crossing CTO device segment is expected to grow at a high rate over the forecast period (2023-2030). A Crossing CTO device is a unique system designed to achieve intraluminal penetration over long occlusions. It is approved for coronary and peripheral applications. The generator is controlled with a footswitch, a high-frequency transducer, and the Crosser catheter. The increasing number of clinical studies on crossing CTO devices and U.S. FDA approvals are among the key factors fueling the U.S peripheral CTO device market growth.

For instance, on March 6, 2020, Reflow Medical was granted U.S. FDA 510(K) clearance for an expanded indication for the Wingman catheter to cross chronic total occlusions (CTOs) in peripheral artery disease. Furthermore, SoundBite Medical Solutions, Inc. has started recruiting for a clinical study on SoundBite Crossing System &ndash; Peripheral. Thus, the increasing number of clinical trials on crossing CTO devices and new product approvals ensure the crossing CTO device segment dominance over the market. &nbsp;

<h3>U.S. Peripheral CTO Device Market Companies and&nbsp;Competitive Landscape</h3>

The major players operating in the U.S. peripheral CTO devices market are Medtronic, Boston Scientific Corporation, Avinger, Inc., Cardinal Health, Koninklijke Philips N.V., Cook Medical Incorporated, C.R. Bard, Baylis Medical Company, BTG Vascular, and Soundbite Medical Solutions. The key players are adopting various strategies such as product launches, mergers &amp; acquisitions, partnerships, and collaborations, contributing to the U.S. peripheral CTO devices market growth. For instance, AUG 31, 2022, Medtronic partnered with BioIntelliSense for exclusive U.S. distribution of multi-parameter wearables for continuous remote patient monitoring from in-hospital to home. Also, AUG 30, 2022, Medtronic acquired Affera.

Medtronic, Plc.

Overview: 

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

Medtronic plc&rsquo;s product portfolio for U.S. Peripheral CTO Device has Viance Crossing Catheter, Enteer Re-Entry System.

The U.S. peripheral CTO device market report, would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

<ol>
	<li>&nbsp;Methodology and Scope
	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>Market Definition and Overview</li>
	<li>Executive Summary</li>
	<li>Market Dynamics
	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing Number of Regulatory Approvals</li>
				<li>Innovations and Developments</li>
				<li>The Growing Need for Peripheral CTO Device​</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Restraints
		<ol>
			<li>
			<ol>
				<li>Availability of Substitute Devices</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Industry Analysis
	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Regulatory Analysis</li>
	</ol>
	</li>
	<li>COVID-19 Analysis
	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturer&rsquo;s Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>By Device Type
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type Segment</li>
			<li>Market Attractiveness Index, Device Type Segment</li>
		</ol>
		</li>
		<li>Crossing CTO Device
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li>
		</ol>
		</li>
		<li>TruePath</li>
		<li>Viance Device</li>
		<li>Re-entry Device</li>
		<li>CenterCross CTO Device</li>
		<li>Prodigy and CrossLock</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By End User
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment</li>
			<li>Market Attractiveness Index, By End User Segment</li>
		</ol>
		</li>
		<li>Hospitals
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li>
		</ol>
		</li>
		<li>Ambulatory Surgical Centers</li>
		<li>Others</li>
	</ol>
	</li>
	<li>Competitive Landscape
	<ol>
		<li>Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
	</ol>
	</li>
	<li>Company Profiles
	<ol>
		<li>Medtronic Plc
		<ol>
			<li>&nbsp;Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Boston Scientific Corporation</li>
		<li>Avinger, Inc.</li>
		<li>Cardinal Health</li>
		<li>Koninklijke Philips N.V.</li>
		<li>Cook Medical Incorporated</li>
		<li>C.R Bard</li>
		<li>Baylis Medical Company</li>
		<li>BTG Vascular</li>
		<li>Soundbite Medical Solutions(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>DataM Intelligence
	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

&nbsp;List of Tables

Table No 1 U.S Peripheral CTO Device Market Value, By Device Type, 2021, 2025 &amp; 2029 ($ Million)

Table No 2 U.S Peripheral CTO Device Market Value, By End User, 2021, 2025 &amp; 2029 ($ Million)

Table No 3 U.S Peripheral CTO Device Market Value, By Device Type, 2021, 2025 &amp; 2029 ($ Million)

Table No 4 U.S Peripheral CTO Device Market Value, By Device Type, 2020-2029 ($ Million)

Table No 5 U.S Peripheral CTO Device Market Value, By End User, 2021, 2025 &amp; 2029 ($ Million)

Table No 6 U.S Peripheral CTO Device Market Value, By End User, 2020-2029 ($ Million)

Table No 7 Medtronic Plc: Overview

Table No 8 Medtronic Plc: Product Portfolio

Table No 9 Medtronic Plc: Key Developments

Table No 10 Cardinal Health: Overview

Table No 11&nbsp; Cardinal Health: Product Portfolio

Table No 12 Cardinal Health: Key Developments

Table No 13 Koninklijke Philips N.V.: Overview

Table No 14 Koninklijke Philips N.V.: Product Portfolio

Table No 15 Koninklijke Philips N.V.: Key Developments

Table No 16 Cook Medical Incorporated: Overview

Table No 17 Cook Medical Incorporated: Product Portfolio

Table No 18 Cook Medical Incorporated: Key Developments

Table No 19 C.R Bard: Overview

Table No 20 C.R Bard: Product Portfolio

Table No 21 C.R Bard: Key Developments

Table No 22 Baylis Medical Company: Overview

Table No 23 Baylis Medical Company: Product Portfolio

Table No 24 Baylis Medical Company: Key Developments

Table No 25 BTG Vascular: Overview

Table No 26 BTG Vascular: Product Portfolio

Table No 27 BTG Vascular: Key Developments

Table No 28 Soundbite Medical Solutions: Overview

Table No 29 Soundbite Medical Solutions: Product Portfolio

Table No 30 Soundbite Medical Solutions: Key Developments

Table No 31 Boston Scientific Corporation: Overview

Table No 32 Boston Scientific Corporation: Product Portfolio

Table No 33 Boston Scientific Corporation: Key Developments

Table No 34 Avinger, Inc.: Overview

Table No 35 Avinger, Inc.: Product Portfolio

Table No 36 Avinger, Inc.: Key Developments

List of Figures

Figure No 1&nbsp; U.S Peripheral CTO Device Market Share, By Device Type, 2021 &amp; 2029 (%)

Figure No 2 U.S Peripheral CTO Device Market Share, By End User, 2021 &amp; 2029 (%)

Figure No 3 U.S Peripheral CTO Device Market Value, 2020-2029 ($ Million)

Figure No 4 U.S Peripheral CTO Device Market Y-o-Y Growth, By Device Type, 2021-2029 (%)

Figure No 5 Crossing CTO Device: U.S Peripheral CTO Device Market Value, 2020-2029 ($ Million)

Figure No 6 TruePath: U.S Peripheral CTO Device Market Value, 2020-2029 ($ Million)

Figure No 7 Viance Device: U.S Peripheral CTO Device Market Value, 2020-2029 ($ Million)

Figure No 8 Re-entry Device: U.S Peripheral CTO Device Market Value, 2020-2029 ($ Million)

Figure No 9 CenterCross CTO Device: U.S Peripheral CTO Device Market Value, 2020-2029 ($ Million)

Figure No 10 Prodigy and CrossLock: U.S Peripheral CTO Device Market Value, 2020-2029 ($ Million)

Figure No 11 Others: U.S Peripheral CTO Device Market Value, 2020-2029 ($ Million)

Figure No 12 U.S Peripheral CTO Device Market Y-o-Y Growth, By End User, 2021-2029 (%)

Figure No 13 Hospitals: U.S Peripheral CTO Device Market Value, 2020-2029 ($ Million)

Figure No 14 Ambulatory Surgical Centers: U.S Peripheral CTO Device Market Value, 2020-2029 ($ Million)

Figure No 15 Others: U.S Peripheral CTO Device Market Value, 2020-2029 ($ Million)

Figure No 16 Medtronic Plc: Financials

Figure No 17 Cardinal Health: Financials

Figure No 18 Koninklijke Philips N.V.: Financials

Figure No 19 Cook Medical Incorporated: Financials

Figure No 20 C.R Bard: Financials

Figure No 21 Baylis Medical Company: Financials

Figure No 22 BTG Vascular: Financials

Figure No 23 Soundbite Medical Solutions: Financials

Figure No 24 Boston Scientific Corporation: Financials

Figure No 25 Avinger, Inc.: Financials